Floatz logo

10 assets in Cancer-Related Condition

Therapeutic assets addressing Cancer-Related Condition, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Oxycodone
Cancer-Related Condition
Deventer ZiekenhuisP4BB (68)
Lidocaine
Cancer-Related Condition
National and Kapodistrian University of AthensP2/3BB (67)
Nepenthe
Cancer-Related Condition
Instituto Nacional de Cancer, BrazilP3BB (66)
Propofol
Cancer-Related Condition
Nyree PennP1CC (43)
Duloxetine
Cancer-Related Condition
Assiut UniversityN/AD (30)
ha35
Cancer-Related Condition
Nakhia Impex LLCN/AD (30)
(±)-Tramadol
Cancer-Related Condition
Assiut UniversityN/AD (30)
Abiraterone
Cancer-Related Condition
Deventer ZiekenhuisP4NR ()
Nanocrystalline Megestrol Acetate Suspension
Cancer-Related Condition
Guangzhou Institute of Respiratory DiseaseP2NR ()
Nano-Crystalline Megestrol Acetate Suspension
Cancer-Related Condition
Shandong Cancer Hospital and InstituteN/ANR ()